DNA Synthesis Related News

Ginkgo Bioworks Acquires Leading Synthetic DNA Provider Gen9

BOSTON, Jan. 20, 2017 /PRNewswire/ -- Ginkgo Bioworks, the organism company, announced today the acquisition of Gen9, a pioneer in the synthesis and assembly of DNA. The acquisition will bring Gen9's unique expertise in assembling pathway-length synthetic DNA into Ginkgo's [...]

Eurofins Genomics Expands Express Oligo Service

LOUISVILLE, Ky., Jan. 16, 2017 /PRNewswire/ -- Eurofins Genomics today announced the expansion of its Express Oligo service, which will allow more customers to receive their primers in a shorter turnaround time, without the usual price premium or compromise in quality [...]

By | January 20th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Synthomics Announces Completion Of Seed Financing And Launch Of Early Access Program For Next-generation DNA Synthesis Platform

MENLO PARK, Calif., Jan. 18, 2017 /PRNewswire/ -- Synthomics, Inc., an emerging developer of next-generation systems for oligonucleotide synthesis, announced today that it has completed seed round financing and has launched an early access program for its end-to-end DNA synthesis platform. [...]

By | January 20th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Molecular Assemblies Takes on the Next Generation of DNA Synthesis

Synthetic biology has a problem. That problem is DNA. A claim like this may seem puzzling up against a synbio world that is booming with more DNA than ever before. Last year, organism developer Ginkgo Bioworks alone purchased DNA in [...]

By | January 11th, 2017|DNA Synthesis, Industry Providers, News|

Twist Bioscience Supplying 3.2kB Genes to Ginkgo Bioworks

SAN FRANCISCO, Calif. – January 10, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis on silicon, today announced that it is now shipping genes up to 3,200 base pairs (3.2 kilobase or kB) [...]

By | January 10th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Synpromics announces a research collaboration with GE Healthcare to Extend the Toolbox for Production of Biologics

Edinburgh, UK, 4th January 2017 / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform. Synpromics will [...]